Joseph M. Lane, MD Chief
• The Service received a four-year grant renewal to continue to study bone drug holiday and is also pursuing studies to determine bone architectural characteristics in patients with atypical femoral fractures and in individuals on long-term bisphosphonates without fractures. • A major research initiative, in collaboration with Cornell University, is defining the mechanical properties as they relate to sugar in the bones of diabetic patients. If sugar is causing bone weakening, the theory is that perhaps certain medications can remove the sugar from the bones.
• The Seymour Cohn Metabolic Bone Registry, which analyzes patient data to identify methods to prevent and repair fragility fractures, has recruited 540 participants since its launch in 2007.
EDUCATION UPDATES • The Metabolic Bone Disease Fellowship provides fellows with the clinical knowledge and research skills necessary for a successful career in academic orthopaedics and/or medicine; some 90 percent of fellows have gone on to pursue academic careers. • Dr. Libi Galmer, a 2014 graduating fellow, is involved in clinical research projects that include the effects of
Juliet B. Aizer, MD, MPH Panagiota (Penny) Andreopoulou, MD Richard S. Bockman, MD, PhD Adele L. Boskey, PhD Azeez M. Farooki, MD Steven R. Goldring, MD Marci Anne Goolsby, MD Martin Nydick, MD Linda A. Russell, MD Alana C. Serota, MD Robert Schneider, MD
vitamin D on muscle function, outcomes of nonunions treated with the Hernigou procedure, avascular necrosis in patients treated with steroids, and adrenal suppression in patients treated with epidural steroid injections.
• The Service has long been actively involved in medical student education, including offering a shadowing program in the care of metabolic bone disease patients and a oneyear “Step Out” that enables third-year medical students to conduct metabolic bone research. Metabolic Bone Disease/Musculoskeletal Oncology Service
21